KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Deferred Taxes (2016 - 2025)

Quest Diagnostics' Deferred Taxes history spans 17 years, with the latest figure at -$13.0 million for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 138.24% year-over-year to -$13.0 million; the TTM value through Dec 2025 reached $105.0 million, up 707.69%, while the annual FY2025 figure was $105.0 million, 707.69% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$13.0 million at Quest Diagnostics, down from $110.0 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $110.0 million in Q3 2025 and bottomed at -$44.0 million in Q4 2022.
  • The 5-year median for Deferred Taxes is -$1.5 million (2023), against an average of $7.8 million.
  • The largest annual shift saw Deferred Taxes soared 3150.0% in 2022 before it plummeted 350.0% in 2024.
  • A 5-year view of Deferred Taxes shows it stood at $30.0 million in 2021, then tumbled by 246.67% to -$44.0 million in 2022, then surged by 77.27% to -$10.0 million in 2023, then soared by 440.0% to $34.0 million in 2024, then tumbled by 138.24% to -$13.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Deferred Taxes are -$13.0 million (Q4 2025), $110.0 million (Q3 2025), and $1.0 million (Q2 2025).